Study of Monochromatic X-ray Mammography System
This research study is looking at a new 2-D Monochromatic X-ray Mammography System. This system uses a special type of X-ray that may create better images with less radiation than regular mammograms. The study wants to see if this new system works as well as or better than traditional mammography. You may be able to join if you are a woman aged 40 or older, have had a mammogram before, and have not had breast cancer surgery or treatment. The study aims to enroll 52 participants, but its current recruitment status is unclear.
- Study design
- This is a single-arm, non-blinded study that will compare the new system to traditional mammography. It plans to enroll 52 participants.
- What's involved
- You would have a mammogram with the new system during one visit, and possibly a follow-up visit up to 7 days later.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary goal is measured from enrollment to the end of your visit, or up to 7 days after if needed.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Study of Monochromatic X-ray Mammography System
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Lars Grimm, MD · PRINCIPAL_INVESTIGATOR · Duke Health
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Noninferiority of a 2-D monochromatic X-ray mammography system compared to conventional mammographyEnrollment to end of visit 1 (or up to 7 days following visit 1, if needed)
Demonstrate that a 2-D monochromatic X-ray mammography system can produce mammographic images using lower radiation dose (at least 20% less than conventional mammography), yet, not inferior to conventional mammography. \[Likert scale 1-3. Higher score is a better outcome\]